Being 'evidence-based' in the absence of evidence: The management of non-evidence in guideline development

Social Studies of Science

Volumn 43, Issue 5, 2013, Pages 681-706

  Knaapen, Loes ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

clinical practice guidelines; evidence; Evidence Based Medicine; nonknowledge; regulatory objectivity; standards; uncertainty

Indexed keywords

EID: 84884493787     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312713483679     Document Type: Article

References (76)

1. AGREE (n.d.) AGREE: Advancing the science of practice guidelines. Available at: http://www.agreetrust.org/ (accessed 7 August 2012).
2. Armstrong D.Clinical autonomy, individual and collective: The problem of changing doctors' behaviour.Social Science & Medicine. 2002;55 (10): 1771-1777.
3. Armstrong D.Professionalism, indeterminacy and the EBM Project.BioSocieties. 2007;2 (1): 73-84.
4. Berg M,Timmermans S.Orders and their others: On the constitution of universalities in medical work.Configurations. 2000;8 (1): 31-61.
5. Berg M,Horstman K,Plass S,van Heusden M.Guidelines, professionals and the production of objectivity: Standardisation and the professionalisation of insurance medicine.Sociology of Health & Illness. 2000;22 (6): 765-791.
6. Black D.The limitations of evidence.Perspectives in Biology and Medicine. 1998;42 (1): 1-7.
7. Blomgren M,Sahlin KTranscending New Public Management: The Transformation of Public Sector Reforms. Christensen TLægreid P, ed. Aldershot: Ashgate Publishing; 2007:155-177.
8. Bluhm R.From hierarchy to network: A richer view of evidence for evidence-based medicine.Perspectives in Biology and Medicine. 2005;48 (4): 535-547.
9. Borgerson K.Evidence-based alternative medicine?.Perspectives in Biology and Medicine. 2005;48 (4): 502-515.
10. Böschen S,Kastenhofer K,Rust I,Soentgen J,Wehling P.Scientific nonknowledge and its political dynamics: The cases of agri-biotechnology and mobile phoning.Science, Technology & Human Values. 2010;35 (6): 783-811.
11. Bowker GC,Star SLSorting Things Out: Classification and Its Consequences. Cambridge, MA: MIT Press; 2000:.
12. Browman G,Levine MN, Mohide E, Hayward RS, Prtichard KI, et al.The practice guidelines development cycle: A conceptual tool for practice guidelines development and implementation.Journal of Clinical Oncology. 1995;13 (2): 502-512.
13. Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, et al.Grading quality of evidence and strength of recommendations in clinical practice guidelines.Allergy. 2009;64 (5): 669-677.
14. Buetow M,Kenealy T.Evidence-based medicine: The need for a new definition.Journal of Evaluation in Clinical Practice. 2000;6 (2): 85-92.
15. Cambrosio A,Keating P,Schlich T,Weisz G.Regulatory objectivity and the generation and management of evidence in medicine.Social Science & Medicine. 2006;63 (1): 189-199.
16. Cambrosio A,Keating P,Schlich T,Weisz G.Biomedical conventions and regulatory objectivity: A few introductory remarks.Social Studies of Science. 2009;39 (5): 651-664.
17. Cartwright N.Are RCTs the gold standard?.BioSocieties. 2007;2 (1): 11-20.
18. Castel P.What's behind a guideline? Authority, competition and collaboration in the French oncology sector.Social Studies of Science. 2009;39 (5): 743-764.
19. Castel P,Merle I.Quand les normes de pratiques deviennent une ressource pour les médecins.Sociologie du Travail. 2002;44 (3): 337-355.
20. Cronje R,Fullan A.Evidence-based medicine: Toward a new definition of 'rational' medicine.Health. 2003;7 (3): 353-369.
21. Daston L,Galison PObjectivity. Brooklyn, NY: Zone Books; 2007:.
22. Djulbegovic B,Morris L,Lyman GH.Evidentiary challenges to evidence-based medicine.Journal of Evaluation in Clinical Practice. 2000;6 (2): 99-109.
23. Dobrow MJ,Goel V,Lemieux-Charles L,Black NA.The impact of context on evidence utilization: A framework for expert groups developing health policy recommendations.Social Science & Medicine. 2006;63 (7): 1811-1824.
24. EBRO (2007) Handleiding voor werkgroepleden [Manual for working group members]. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO. Available at: http://www.cbo.nl/Downloads/1250/EBRO_handleiding.pdf (accessed 20 July 2012).
25. EBRO (n.d.) Formulier Vc voor het beoordelen van een Systematische Review van Observationeel Onderzoek [Form Vc to assess systematic reviews of observational research]. Available at: http://dcc.cochrane.org/sites/dcc.cochrane.org/files/uploads/SR-Obs.pdf (accessed 12 April 2012)
26. Epstein SInclusion: The Politics of Difference in Medical Research. Chicago, IL: University of Chicago Press; 2007:.
27. Evidence-based medicine. A new approach to teaching the practice of medicine.Journal of the American Medical Association. 1992;268 (17): 2420-2425.
28. Freidson E.The changing nature of professional control.Annual Review of Sociology. 1984;10:1-20.
29. Garsten C,Lindh De Montoya MTransparency in a New Global Order: Unveiling Organizational Visions. Garsten CLindh De Montoya M, ed. Cheltenham: Edward Elgar; 2008:1-21.
30. Goldenberg MJ.Iconoclast or creed? Objectivism, pragmatism, and the hierarchy of evidence.Perspectives in Biology and Medicine. 2009;52 (2): 168-187.
31. Goldenberg MJ,Borgerson K,Bluhm R.The nature of evidence in evidence-based medicine.Perspectives in Biology and Medicine. 2009;52 (2): 164-167.
32. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, et al.Grading quality of evidence and strength of recommendations.British Medical Journal. 2004;328:1490-1494.
33. Graham ID, Beardall S, Carter AO, Glennie J, Hébert PC, et al.What is the quality of drug therapy clinical practice guidelines in Canada?.Canadian Medical Association Journal. 2001;165 (2): 157-163.
34. Grossman J,Mackenzie FJ.The randomized controlled trial: Gold standard, or merely standard?.Perspectives in Biology and Medicine. 2005;48 (4): 516-534.
35. Guidelines International Network (n.d.) About Guidelines International Network. Available at: www.g-i-n.net/about-g-i-n (accessed 15 July 2011).
36. Guyatt GH,Meade MO,Jaeschke RZ,Cook DJ,Haynes RB.Practitioners of evidence based care: Not all clinicians need to appraise evidence from scratch but all need some skills.British Medical Journal. 2000;320:954-955.
37. Keating P,Cambrosio A.Who's minding the data? Data monitoring committees in clinical cancer trials.Sociology of Health & Illness. 2009;31 (3): 325-342.
38. Knaapen LEuropean Union Public Health Policy: Regional and Global Trends. Greer SKurzer P, ed. London: Routledge; 2012:64-80.
39. Knaapen L,Cazeneuve H,Cambrosio A,Castel P,Fervers B.Pragmatic evidence and textual arrangements: A case study of French clinical cancer guidelines.Social Science & Medicine. 2010;71 (4): 685-692.
40. Knorr-Cetina KEpistemic Cultures: How the Sciences Make Knowledge. Cambridge, MA: Harvard University Press; 1999:.
41. Evidence-Based Medicine: In Its Place. Kristiansen IMooney G, ed. London: Routledge; 2004:.
42. Lambert H.Accounting for EBM: Notions of evidence in medicine.Social Science & Medicine. 2006;62 (11): 2633-2645.
43. Standards and Their Stories: How Quantifying, Classifying, and Formalizing Practices Shape Everyday Life. Lampland MStar SL, ed. Ithaca, NY: Cornell University Press; 2009:.
44. Latimer J,Featherstone K,Atkinson P,Clarke A,Pilz DT.Rebirthing the clinic: The interaction of clinical judgment and genetic technology in the production of medical science.Science, Technology & Human Values. 2006;31 (5): 599-630.
45. Latour BReassembling the Social: An Introduction to Actor-Network-Theory. New York: Oxford University Press; 2007:.
46. Levay C,Waks C.Professions and the pursuit of transparency in healthcare: Two cases of soft autonomy.Organization Studies. 2009;30 (5): 509-527.
47. McGivern G,Fischer MD.Reactivity and reactions to regulatory transparency in medicine, psychotherapy and counselling.Social Science & Medicine. 2012;74 (3): 289-296.
48. McGoey L.Pharmaceutical controversies and the performative value of uncertainty.Science as Culture. 2009;18 (2): 151-164.
49. McGuire WL.Beyond EBM: New directions for evidence-based public health.Perspectives in Biology and Medicine. 2005;48 (4): 557-569.
50. Monaghan M.The evidence base in UK drug policy: The new rules of engagement.Policy and Politics. 2008;36:145-150.
51. Moreira T.Diversity in clinical guidelines: The role of repertoires of evaluation.Social Science & Medicine. 2005;60 (9): 1975-1985.
52. Moreira T.Entangled evidence: Knowledge making in systematic reviews in healthcare.Sociology of Health & Illness. 2007;29 (2): 180-197.
53. Moreira T,May C,Bond J.Regulatory objectivity in action: Mild cognitive impairment and the collective production of uncertainty.Social Studies of Science. 2009;39 (5): 665-690.
54. National Institute for Health and Clinical Excellence (2011) New database to inform prioritisation of European cancer research. Available at: http://www.nice.org.uk/newsroom/news/newsarchive/2009/canceruncertainties.jsp (accessed 23 July 2011).
55. Norris SL.Clinical practice guidelines and scientific evidence (Letters to the editor).Journal of the American Medical Association. 2009;302 (2): 142-147.
56. Petty J,Heimer CA.Extending the rails: How research reshapes clinics.Social Studies of Science. 2011;41 (3): 337-360.
57. Porter TMTrust in Numbers: The Pursuit of Objectivity in Science and Public Life. Princeton, NJ: Princeton University Press; 1995:.
58. PostPKuijpersTSchünemannHLangeSMagriniN (2009) Using the GRADE approach in osteoporosis guideline development: Application and interpretation of indirectness. In: Workshop WS09 at Guidelines International Network conference. Available at: http://www.g-i-n.net/events/6th-conference/tuesday-november-3rd-2009 (accessed 10 January 2013).
59. Power MThe Audit Society: Rituals of Verification. Oxford: Oxford University Press; 1999:.
60. Power M.'The Audit Society': Second thoughts.International Journal of Auditing. 2000;4:111-119.
61. Program in Evidence-Based Care (2007) Proceedings of the 1st Scientific Symposium 'The Nature of Evidence', Toronto, ON, Canada, 28 February. Available at: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=39496 (accessed 12 May 2012).
62. Qaseem A, Forland F, Macbeth F, Ollenschläger G, Phillips S, et al.Guidelines International Network: Toward international standards for clinical practice guidelines.Annals of Internal Medicine. 2012;156 (7): 525-531.
63. Rabeharisoa V,Bourret P.Staging and weighting evidence in biomedicine: Comparing clinical practices in cancer genetics and psychiatric genetics.Social Studies of Science. 2009;39 (5): 691-715.
64. Sackett DL,Straus SE,Richardson WS,Rosenberg W,Haynes RBEvidence-Based Medicine: How to Practice and Teach EBM. Edinburgh and New York: Churchill Livingstone; 2000:.
65. Sackett DL,Rosenberg WM.The need for evidence-based medicine.Journal of the Royal Society of Medicine. 1995;88 (11): 620-624.
66. Smith B.Evidence-based medicine (Letters to the editor).British Medical Journal. 1996;313 (7050): 169-171.
67. Timmermans S.The joy of science: Finding success in a 'failed' randomized clinical trial.Science, Technology & Human Values. 2011;36 (4): 549-572.
68. Timmermans S,Berg MThe Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Philadelphia, PA: Temple University Press; 2003:.
69. Tonelli MR.Integrating evidence into clinical practice: An alternative to evidence-based approaches.Journal of Evaluation in Clinical Practice. 2006;12 (3): 248-256.
70. Townley C.Toward a revaluation of ignorance.Hypatia. 2006;21 (3): 37-55.
71. Tricoci P,Allen JM,Kramer JM,Califf RM,Smith SC.Scientific evidence underlying the ACC/AHA clinical practice guidelines.Journal of the American Medical Association. 2009;301 (8): 831-841.
72. Tuana N.Coming to understand: Orgasm and the epistemology of ignorance.Hypatia. 2004;19 (1): 194-232.
73. Verkerk K,Van Veenendaal H,Severens JL,Hendriks EJ,Burgers JS.Considered judgment in evidence-based guideline development.International Journal for Quality in Health Care. 2006;18 (5): 365-369.
74. Weisz G, Cambrosio A, Keating P, Knaapen L, Schlich T, et al. The emergence of clinical practice guidelines. Milbank Quarterly 2007; 85(4): 691-727.
75. Will CM.Identifying effectiveness in 'The Old Old': Principles and values in the age of clinical trials.Science, Technology & Human Values. 2009;34 (5): 607-628.
76. Will CMMedical Proofs, Social Experiments: Clinical Trials in Shifting Contexts. Will CMoreira T, ed. Farnham: Ashgate Publishers; 2010:67-83.